Suberoylanilide hydroxamic acid (SAHA vorinostat) causes bone loss by inhibiting immature osteoblasts

Target Article

Suberoylanilide hydroxamic acid (SAHA vorinostat) causes bone loss by inhibiting immature osteoblasts; ME McGee; 2011; doi_citing_unknown

Retraction

Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy  ; Yoshihiro Sato Izumi Kondo S Ishida H Motooka K Takayama Y Tomita H Maeda Kei Satoh; 08/14/2001

https://doi.org/10.?1212/?WNL.?57.?3.?445

Citation piece

Note: Open to append information.